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PATHOGEN- OR ELICITOR-INDUCIBLE 
TRANSCRIPTION REGULATORY ELEMENT 
FROM THE TOBACCO 
5-EPI-ARISTOLOCHENE SYNTHASE GENE 
AND PLANTS TRANSFORMED THEREWITH 
This application is a continuation of Ser. No. 08/443,639, 
now US. Pat. No. 5,981,843, Which Was ?led on May 18, 
1995, the disclosure of Which is hereby incorporated by 
reference. 
This invention Was made, at least in part, With funding 
from the National Science Foundation and the United States 
Department of Agriculture. Accordingly, the United States 
Government may have certain rights in this invention. 
THE FIELD OF THE INVENTION 
The ?eld of this invention is the area of plant molecular 
biology, and it relates in particular to transcription regulatory 
elements: a qualitative regulatory sequence Which positively 
regulates doWnstream gene expression in plant tissue in 
response to the stress of an invading microbial pathogen, an 
elicitor, or other inducing chemical signals and quantitative 
regulatory sequences Which increase the transcriptional 
expression of associated sequences. 
THE BACKGROUND OF THE INVENTION 
In plants, disease resistance to fungal, bacterial and viral 
pathogens is associated With a plant response termed the 
hypersensitivity response In the HR, the site in the 
plant Where the potential phytopathogen invades undergoes 
localiZed cell death, and it is postulated that this localiZed 
plant cell death aspect of the HR contains the invading 
microorganism or virus, thereby protecting the remainder of 
the plant. Other plant defenses include the production of 
phytoalexins (antibiotics) and/or lytic enZymes capable of 
averting pathogen ingress and/or cell Wall modi?cations 
Which strengthen the plant cell Wall against physical and/or 
enZymatic attack. 
The HR of plants, including tobacco, can include phy 
toalexin production as part of the response to invading 
microorganisms. One class of compounds made by tobacco 
(Nicotiana tabacum) in response to microbial invaders are 
the sesquiterpenes. 
Cell suspension cultures have provided useful informa 
tion regarding the regulation of terpene synthesis. Iso 
prenoids are ubiquitous in nature, and the early portions of 
the biosynthetic pathWay are shared With the biosynthetic 
pathWay for other isoprenoid compounds such as sterols, 
carotenoids, dolichol and ubiquinone and groWth regulators 
(e.g., gibberellic acid), Which are classi?ed as primary 
metabolites. Isoprenoid compounds classi?ed as secondary 
metabolites are not essential for groWth, and include mono-, 
sesqui- and diterpenoids. These secondary metabolite iso 
prenoids are important mediators of interactions betWeen the 
plant and its environment. 
A variety of compositions can serve as elicitors of plant 
phytoalexin synthesis. These include, but are not limited to, 
one or more toxic ions, e.g., mercuric ions, other chemically 
de?ned compositions, metabolic inhibitors, cell Wall 
glycans, certain glycoproteins, certain enzymes, fungal 
spores, chitosans, certain fatty acids and certain oligosac 
charides derived from plant cell Walls [See, e.g., Sequeira, L. 
(1983) Annu. Rev. Microbiol. 37:51—79 and references cited 
therein]. Epi-5-aristolochene synthase (EAS) activity in 
tobacco plants has been shoWn to be induced by cell Wall 
fragments of certain Phytophthora species and by Tricho 
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derma reesei cellulase but not Aspergillus japonicum pec 
tolyase [Chappell et al. (1991) Plant Physiol. 97:693—698]. 
Attack by other plant pathogens or an avirulent related strain 
can also induce phytoalexin synthesis; for example, 
Pseudomonas lachrymans induces sesquiterpenoid synthe 
sis in tobacco [Guedes et al. (1982) Phytochemistry 
21:2987—2988]. 
Elicitins are proteins Which are produced by plant patho 
gens and potential plant pathogens, Which proteins induce 
the HR in tobacco plants. Amino acid and nucleotide coding 
sequences for an elicitin of Phytophthora parasitica have 
been published [Kamoun et al. (1993) Mol. Plant-Microbe 
Interactions 6:573—581]. Plant pathogenic viruses including, 
but not limited to, Tobacco Mosaic Virus (TMV) induce the 
HR in infected plants. Bacteria Which infect plants also can 
induce HR and thereby disease resistance; representative 
bacteria eliciting HR include, but are not limited to, Agro 
bacterium species, Xanthomonas species and Pseudomonas 
syringae. Plant pathogenic fungi (and certain avirulent 
strains as Well) also induce the HR response, Where these 
include, but are not limited to, Phytophthora parasitica and 
Peronospora tabaci. 
When tobacco cell suspension cultures are treated With an 
elicitor, squalene synthetase is suppressed, thus stopping the 
How of common biosynthetic precursors into sterols. The 
concomitant induction of sesquiterpene cyclase gene expres 
sion causes the How of precursors in sesquiterpenes. The 
?rst step in the pathWay from farnesyl diphosphate to the 
sesquiterpene phytoalexin capsidiol in elicitor-induced 
tobacco tissue is catalyZed by 5-epi-aristolochene synthase 
(EAS), a sesquiterpene cyclase. The coding sequence and 
deduced amino acid sequence for one member of the EAS 
gene family of tobacco have been published [Facchini and 
Chappell (1992) Proc. Natl. Acad. Sci. USA 
89:11088—11092]. The transcriptional expression of one or 
more members of the EAS gene family is induced in 
response to elicitors. 
There is a long felt need in the art for methods of 
protecting plants, particularly crop plants, from infection by 
plant pathogens, including but not limited to, phytopatho 
genic viruses, fungi and/or bacteria. Especially important 
from the standpoint of economics and environmental con 
cerns are biological or “natural” methods rather than those 
Which depend on the application of chemicals to crop plants. 
There is also a long felt need in the art for plant transcrip 
tional regulatory sequences for use in controlling the expres 
sion of heterologous DNA sequences in transgenic plants. 
SUMMARY OF THE INVENTION 
The present invention provides qualitative transcriptional 
regulatory sequences Which regulate doWnstream gene 
expression in plant tissue in response to one or more 
elicitors, other de?ned inducing compounds or in response 
to the stress of an invading phytopathogen (the inducible 
transcription regulatory sequence) and quantitative tran 
scription regulatory sequences Which increase the transcrip 
tion of doWnstream sequences (the transcription-enhancing 
sequence). As speci?cally exempli?ed herein, these tran 
scriptional regulatory sequences are found in nature 
upstream and operatively linked to the epi-5-aristolochene 
synthase gene (EAS4) of tobacco; When operatively linked 
to a coding sequence (and in the presence of an operatively 
linked promoter element, from the EAS4 gene or from a 
heterologous plant-expressible gene) these sequences medi 
ate the inducible transcriptional expression of that coding 
sequence When the plant or plant tissue is invaded by a 
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potential phytopathogen (virus, fungus or bacterium) or in 
response to elicitors such as T richoa'erma viride cellulase or 
plant or fungal cell Wall fragments for plants, plant tissue 
and/or plant suspension culture cells. That potential plant 
pathogen can be a virus including, but not limited to, tobacco 
mosaic virus or tobacco vein mottle virus, a bacterium 
including, but not limited to, Pseudomonas syringae, Xan 
thomonas campestris or Agrobacterium tumefaciens, or a 
fungus including, but not limited to, a species of Phytoph 
thora (e.g., R parasitica) or Peronospora (e.g., R tabaci). 
The EAS4 promoter comprising the inducible transcription 
regulatory element(s) and the transcription-enhancing 
sequence(s) are disclosed herein as SEQ ID NO:2. In SEQ 
ID NO:2, the CAAT-homologous sequence of the EAS4 
promoter is located at nucleotides 513 to 516, and the 
TATA-sequence motif is located at nucleotides 540 to 543. 
The minimal inducible transcriptional regulatory element 
Within the N. tabacum EAS4 upstream sequence is from 
nucleotide 458 to nucleotide 473 of SEQ ID NO:2; option 
ally from 454 to 473; more preferably from nucleotide 413 
to 473 in SEQ ID NO:2 provides the inducible transcrip 
tional regulatory element sequences. 
Another aspect of the present invention is the 
transcription-enhancing element derived from the EAS4 
promoter and promoter-associated sequences. When opera 
tively linked upstream of a promoter, particularly upstream 
of a minimal promoter, this element increases the transcrip 
tional expression of the doWnstream sequences. Transcrip 
tional enhancing activity is mediated by DNA sequence 
information in the region betWeen nucleotides 371 and 463 
in SEQ ID NO:2. Preferably, an EAS4-derived transcription 
enhancing sequence comprises a nucleotide sequence as 
given in SEQ ID NO:2 from nucleotide 371 to nucleotide 
463, more preferably from nucleotide 1 to nucleotide 463, 
and optionally from nucleotide 1 to about nucleotide 1040 of 
SEQ ID NO:7. 
Also provided by the present invention is an expression 
cassette into Which a coding sequence of interest can be 
cloned, and said coding sequence of interest can be 
expressed in plant tissue after the introduction of the unit 
into plant tissue. Apreferred coding sequence of interest is 
that for the ParA1 elicitin protein of Phytophthora para 
sitica. The coding sequence and deduced amino acid 
sequence for the ParA1 protein, including the signal peptide, 
are given in SEQ ID NOs:16 and 17, respectively. The 
coding sequence and deduced amino acid sequences of the 
nature ParA1 protein as ampli?ed and described hereinbe 
loW are given in SEQ ID NOs:18 and 19, respectively. 
Transcription is regulated by the EAS4 promoter sequence 
and promoter-associated regulatory element or by at least 
one of the transcription regulatory elements (inducible and/ 
or transcription-enhancing) operably linked to transcription 
initiation sequences and a heterologous DNA sequence to be 
expressed. 
A further aspect of the present invention are transgenic 
plant cells, plant tissue and plants Which have been geneti 
cally engineered to contain and express a nucleotide 
sequence of interest, preferably a coding sequence, an 
antisense sequence or other sequence, under the regulatory 
control of the inducible transcription regulatory element. It 
is an object of this invention to provide the nucleotide 
sequences Which mediate the induction of the expression of 
a doWnstream coding sequence in response to elicitor 
exposure, potential phytopathogen invasion in a plant, or 
certain other exogenous inducing signals such as exposure to 
methyl jasmonate and ethylene. An exemplary elicitor 
inducible transcription regulatory element is that from the 5‘ 
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?anking region of the EAS4 gene of Nicotiana tabacum; as 
speci?cally exempli?ed herein, this sequence is presented in 
SEQ ID NO:2 from nucleotide 410 to nucleotide 472. 
Equivalents of the exempli?ed nucleotide sequence are 
those nucleotide sequences Which similarly direct the induc 
tion of the expression of doWnstream nucleotide sequences. 
Preferably the inducible transcription regulatory element is 
associated With EAS4 promoter and promoter-associated 
sequences (e.g., the combination having the nucleotide 
sequence as given in SEQ ID NO:2 from nucleotide 410 to 
nucleotide 573 of SEQ ID NO:2, preferably from nucleotide 
361 to 573 of SEQ ID NO:2, more preferably the sequence 
from 1 to 573 of SEQ ID NO:2). 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 presents data for transient expression experiments 
for GUS regulated by the EAS3 and EAS4 promoter region 
sequences in comparison to a CaMV 35S-GUS construct 
(Cauli?oWer Mosaic Virus 35S promoter—[3-glucuronidase 
reporter gene). These experiments Were carried out in 
tobacco protoplasts into Which the DNA constructs had been 
electroporated. “Uninduced” levels of expression for the 
EAS-GUS constructs Were relatively high because fungal 
enZymes Which digest plant cell Walls Were used in the 
preparation of the protoplasts. The y-axis shoWs units of 
GUS activity and the 5‘ extents of the EAS upstream 
sequences are given beloW each bar on the graph. As above, 
the numbering is relative to the natural transcription start site 
of EAS4 (or the corresponding base of EAS3); in EAS4 
(SEQ ID NO:2) the start site is at nucleotide 573; in EAS3 
(SEQ ID NO:1) the potential transcription start site is at 
nucleotide 489. 
FIGS. 2A—2B present information concerning the reporter 
gene expression directed by the instant inducible transcrip 
tion regulatory element. FIG. 2A presents a schematic of 
experiments carried out With the EAS4 promoter region 
controlling the expression of the GUS reporter gene in stably 
transformed transgenic plants. FIG. 2B presents the results 
of “gain of function” assays for the EAS4 promoter 
associated sequence-regulating expression of the GUS 
reporter gene via the CaMV 35S minimal promoter. In both 
FIGS. 2A and 2B, numbering for the EAS4 upstream region 
re?ect numbering relative to the natural transcription start 
site of the EAS4 gene (See also SEQ ID NO:2 Wherein the 
transcription start site corresponds to nucleotide 573). In 
both FIGS. 2A and 2B, the GUS expression is measured in 
Fluorescence units per milligram protein. 
FIG. 3 is a schematic of the genetic manipulation leading 
to generation of disease-resistant plants. The coding 
sequence for the ParA1 elicitin is isolated by PCR so as to 
have BamHI and SstI ends. gEAS46OO-GUS-pBI101, Which 
directs the expression of the GUS reporter gene under the 
regulatory control of the EAS promoter, is digested With 
BamHI and SstI to release the GUS reporter gene. Then the 
BamHI/SstI-digested parA1 amplimer is ligated to the large 
fragment produced after digestion of gEAS46OO-GUS 
pBI101 to produce gEAS46O0-parA1-pBI101, from Which 
the ParA1 elicitin in plant cells or plant tissue is synthesiZed 
after induction With a suitable elicitor. 
DETAILED DESCRIPTION OF THE 
INVENTION 
5 -epi-aristolochene synthase (EAS) is a key enZyme in the 
synthesis of sesquiterpenoid phytoalexins, for example, in 
solanaceous plants, including but not limited to Nicotiana 
species (e.g., tabacum), Capsicum annum and Hyoscyamus 
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muticus. EAS catalyzes the reaction of farnesyl diphosphate 
to (+) gemacrene A to eudesmane carbocation to 5epi 
aristolochene. Other plants, such as the crucifers, also have 
sesquiterpene cyclase enzymes. 
Treatments Which induce host defensive responses in 
plant tissue or plant cells such as phytoalexin synthesis 
include cell Wall fragments of Phytophthora species and 
Trichaa'erma viride cellulase. However, pectolyase from 
Aspergillus japanicus does not function as an elicitor in 
tobacco cell culture. Elicitors Which induce sesquiterpenoid 
phytoalexin synthesis have been shoWn to function at the 
level of controlling transcription of key biosynthetic 
enZymes [Vogeli and Chappell (1990) Plant Physial. 
94:1860—1866]. Similar patterns have been observed in 
other plants, but no transcriptional control sequences Which 
mediate gene induction in response to phytopathogen chal 
lenge have been described. 
Tobacco (N. tabacum) contains an EAS gene family With 
some 12—15 members, the coding sequence of EAS4 has 
been published [Facchini and Chappell (1992) supra]. 
HoWever, since that time, the present inventors have dis 
covered that the EAS3 does not appear to be expressed in 
response to the elicitor treatment, and surprisingly, the 
nucleotide sequences upstream of EAS3 do not appear to 
mediate the induction of a reporter gene in a chimeric gene 
construct in elicitor-induced transgenic cell culture. It is 
noted that the translation start site Was incorrectly identi?ed 
in the 1992 Facchini and Chappell publication. The nucle 
otide sequence of a genomic clone of EAS4, as it appears in 
Facchini and Chappell (1992) supra is presented in SEQ ID 
NO:7, With the deduced amino acid sequence being given in 
SEQ ID NO:8. 
Other aspects of a plant’s defenses against invasion and 
infection by a phytopathogenic microorganism include the 
hypersensitive response, Which is characteriZed by necrosis, 
i.e., programmed cell death in the localiZed area of attack by 
the plant pathogen. Elicitor treatments as described above 
can also induce the necrotic response. 
Elicitins are proteins produced by fungal plant pathogens, 
Which proteins elicit a hypersensitive response in an infected 
plant. Generally, but not necessarily, localiZed cell death is 
the result of the elicitin-induced response in the infected (or 
challenged) plant tissue. These responses mediate full or 
partial resistance to destructive infection by the invading, 
potentially plant pathogenic microorganism. For the pur 
poses of the present invention, a protein of a plant pathogen 
or potential plant pathogen Which induces the hypersensitive 
response in plant tissue after invasion of that plant tissue or 
after expression of that coding sequence in the plant tissue 
is considered to fall Within a broad de?nition of an elicitin. 
A relatively Well-knoWn elicitin of a plant-pathogenic 
fungus is the ParA1 protein of Phytaphthara parasitica. The 
parA1 locus is a member of a gene family [Ricci et al. (1989) 
Eur J. Biachem. 183:555—563]. The coding and amino acid 
sequences for the parA1 gene product are described in 
Kamoun et al. (1993) Mal. Plant-Micrabe Interact. 
4:423—432 and in SEQ ID NOs:12 and 13 herein. 
Other phytopathogen proteins With potential elicitin activ 
ity have been characteriZed as to amino acid sequences and 
other properties [See, e.g., Nespoulous et al. (1992) Plants 
186:551—557; Huet et al. (1992) Phytachemistry 
31:1471—1476; Huet and Pernollet (1992) FEBS Lett. 
257:302—306; Kamoun et al. (1993) Mal. Plant-Micrabe 
Interact. 5:22—33]. Keen, N. T. (1990) Annu. Rev. Phyta 
pathal. 24:447—463 has described an avirulence gene of 
Fulva fulvia. Hammond-Kosack et al. (1994) Prac. Natl. 
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Acad. Sci. USA 91:10445—10449 have described the H 
gene of Cladasparium fulvum, Which functions in the same 
Way as the R parasitica elicitin. 
Certain bacterial plant pathogens also express proteins 
With similar effects on the hypersensitivity response as those 
of the R parasitica ParA1 elicitin. For the purposes of the 
present invention, these proteins fall Within the scope of the 
term “elicitin.” Multiple homologs of the avirulence gene 
mBs3 of Xanthamanas campestris pv. vesicataria have 
been detected in otherX. campestris pathovars [Bonas et al. 
(1989) Mal. Gen. Genet. 218:127—136; Knoop et al. (1991) 
J. Bacterial. 173:7142—7150] and in other species of Xan 
thomonas [De Feyter and Gabriel (1991) Mal. Plant 
Micrabe Interact. 4:423—432; Hopkins et al. (1992) Mal. 
Plant-Micrabe Interact. 5 :451—459]. The MD gene of 
Pseudamanas syringae pv. tamata can confer avirulence; R 
syringaepv. glycinea expresses an altered MD gene product 
[Kobayashi et al. (1990) Mal. Plant-Micrabe Interact. 
3:103—111]. 
It is understood that to be useful in the present invention 
as it applies to creating transgenic plants With improved 
disease resistance traits using an elicitin coding sequence 
expressed under the regulatory control of a pathogen 
response transcription regulatory element (and With a mini 
mal promoter functional in those plants) that elicitin protein 
must be capable of promoting expression of defense genes 
(including but not limited to those genes governing phytoal 
exin synthesis, the hypersensitive response and/or localiZed 
necrosis) in those plants. Many functional combinations of 
plant and phytopathogen are knoWn to the art, and the skilled 
artisan knoWs hoW to test the functioning of a particular 
elicitin in a particular plant tissue (or cells) in the turning on 
of programmed cell death or phytoalexin synthesis or the 
like. It is also understood that treatment of plant cells or 
tissue With compositions such as certain fungal cellulases or 
certain plant polysaccharide fragments can also induce the 
host defensive (i.e., hypersensitive) response. Such treat 
ments are used as models for actual plant pathogen attack or 
invasion. 
A non-naturally occurring recombinant nucleic acid 
molecule, e.g., a recombinant DNA molecule, is one Which 
does not occur in nature; i.e., it is produced either by natural 
processes using methods knoWn to the art, but is directed by 
man to produce a desired result or it has been arti?cially 
produced from parts derived from heterologous sources, 
Which parts may be naturally occurring or chemically syn 
thesiZed molecules or portions thereof, and Wherein those 
parts have been joined by ligation or other means knoWn to 
the art. 
A transgenic plant is one Which has been genetically 
modi?ed to contain and express heterologous DNA 
sequences, either as regulatory RNA molecules or as pro 
teins. As speci?cally exempli?ed herein, a transgenic plant 
is genetically modi?ed to contain and express a heterologous 
DNA sequence operably linked to and under the regulatory 
control of transcriptional control sequences by Which it is 
not normally regulated, i.e., under the regulatory control of 
the inducible transcriptional control sequences of the EAS4 
gene of Nicatiana tabacum. As used herein, a transgenic 
plant also refers to those progeny of the initial transgenic 
plant Which carry and are capable of expressing the heter 
ologous coding sequence under the regulatory control of the 
qualitative and/or quantitative transcription control 
sequences described herein. Seeds containing transgenic 
embryos are encompassed Within this de?nition. 
When production of a heterologous gene or coding 
sequence of interest is desired under conditions of potential 
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pathogen invasion or inducer (e.g., elicitor) treatment, that 
coding sequence is operably linked in the sense orientation 
to a suitable promoter and under the regulatory control of the 
inducible regulatory sequences, in the same orientation as 
the promoter, so that a sense (i.e., functional for translational 
expression) mRNA is produced. A transcription termination 
signal functional in a plant cell can be placed doWnstream of 
the coding sequence, and a selectable marker Which can be 
expressed in a plant, can be covalently linked to the induc 
ible expression unit so that after this DNA molecule is 
introduced into a plant cell or tissue, its presence can be 
selected and plant cells or tissue not so transformed Will be 
killed or prevented from groWing. Similarly, a heterologous 
coding sequence can be expressed under the regulatory 
control of the inducible transcription regulatory element or 
the transcription-enhancing element in transgenic plant cell 
suspension culture, With induction occurring in response to 
the addition of an elicitor to the cell culture medium. 
Where inhibition of gene expression is desired in a plant 
being invaded by a microbial pathogen, such as a phyto 
pathogenic fungus, then either a portion or all of that coding 
sequence or cDNA sequence can be operably linked to a 
promoter functional in plant cells, but With the orientation of 
the coding sequence opposite to that of the promoter (i.e., in 
the antisense orientation) so that the transcribed RNA is 
complementary in sequence to the mRNA, and so that the 
expression of the antisense molecule is induced in response 
to pathogen invasion. In addition, there may be a transcrip 
tional termination signal doWnstream of the nucleotides 
directing synthesis of the antisense RNA. 
The present inventors have isolated a DNA sequence 
Which mediates the inducible expression of a doWnstream 
gene in plant cells in response to invasion by a potential 
plant pathogen and/or treatment With an elicitor or other 
chemical signals. For example, a combination of ethylene 
and methyl jasmonate serve to induce doWnstream gene 
expression via the qualitative transcription regulatory 
sequence. It is understood that there may be a multiplicity of 
sequence motifs Within that regulatory sequence, Where 
individual motifs each respond to one or more distinct 
environmental signal. As speci?cally exempli?ed, this 
transcription-regulating sequence is derived from the EAS4 
locus of N. tabacum, and it is given in SEQ ID NO:7. The 
deduced amino acid sequence for the EAS protein is given 
in SEQ ID NO:8. The open reading frame of the EAS4 gene, 
Which is interrupted by six introns, is provided in SEQ ID 
NO:7. 
A computer search for nucleotide sequence homology in 
sequences in Genbank to the SEQ ID NO:2 sequence 
revealed no knoWn nucleotide sequences With signi?cant 
homology, except for the CAAT and TATA transcriptional 
control sequences. 
OrganiZation of the EAS genes in the N. tabacum genome 
Was described in Facchini and Chappell (1992) supra using 
an EAS probe and Southern hybridiZation experiments. 
Under conditions of high stringency, multiple fragments 
hybridiZed With analysis indicating that there is a gene 
family With some 12—16 members in the tobacco genome. In 
these experiments, hoWever, the probe included the EAS 
coding sequence rather than the promoter and promoter 
associated regulatory sequences. 
EAS homologous genes can be identi?ed and isolated 
from plant species other than N. tabacum based on signi? 
cant degrees of nucleotide sequence homology; i.e., 
DNA:DNA hybridiZation under conditions of moderate to 
high stringency With a tobacco EAS coding sequence probe 
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alloWs the identi?cation of the corresponding gene from 
other plant species. A discussion of hybridiZation conditions 
can be found for example, in Hames and Higgins (1985) 
Nucleic Acid Hybridization, IRL Press, Oxford, UK. Gen 
erally sequences Which have at least about 70% nucleotide 
sequence homology can be identi?ed by hybridiZation under 
conditions of moderate stringency. Under such conditions, it 
is generally preferred that a probe of at least 100 bases be 
used. Most preferably, in the present case, the probe Will be 
derived from the coding portion of the EAS4 coding 
sequence. Labels for hybridiZation probes can include, but 
are not limited to, radioactive groups, ?uorescent groups and 
ligands such as biotin to Which speci?c binding partners 
(Which are in turn labeled) bind. It is the label Which alloWs 
detection of the hybridiZation probe to the target nucleic acid 
molecule. Alternatively, Well-knoWn and Widely accessible 
polymerase chain reaction (PCR) technology is advanta 
geously used to amplify sequences With signi?cant nucle 
otide sequence homology to a target sequence. 
It is understood that nucleic acid sequences other than the 
EAS coding sequence disclosed in SEQ ID NO:7 Will 
function as coding sequences synonymous With the exem 
pli?ed EAS4 coding sequence. Nucleic acid sequences are 
synonymous if the amino acid sequences encoded by those 
nucleic acid sequences are the same. The degeneracy of the 
genetic code is Well-knoWn to the art; i.e., for many amino 
acids, there is more than one nucleotide triplet Which serves 
as the codon for the amino acid. It is also Well-knoWn in the 
biological arts that certain amino acid substitutions can be 
made in protein sequences Without affecting the function of 
the protein. Generally, conservative amino acid substitutions 
or substitutions of similar amino acids are tolerated Without 
affecting protein function. Similar amino acids can be those 
that are similar in siZe and/or charge properties, for example, 
aspartate and glutamate and isoleucine and valine are both 
pairs of similar amino acids. Similarity betWeen amino acid 
pairs has been assessed in the art in a number of Ways. For 
example, Dayhoff et al. (1978) in Atlas of Protein Sequence 
and Structure, Vol. 5, Suppl. 3, pp. 345—352, Which is 
incorporated by reference herein, provides frequency tables 
for amino acid substitutions Which can be employed as a 
measure of amino acid similarity. Dayhoff et al.’s frequency 
tables are based on comparisons of amino acid sequences for 
proteins having the same function from a variety of evolu 
tionarily different sources. 
Terpene cyclase genes can be found in solanaceous plants, 
including N. tabacum and Hyoscyamus muticus, as disclosed 
herein, and in members of the mint family (Labitaceae) and 
the Euphorbiaceae, including but not limited to those Which 
have been demonstrated to contain sequences of signi?cant 
homology, and in substantially all plants. Preferably, EAS4 
homologs Will be selected from the Solanaceae. Such 
sequences can be identi?ed by nucleic acid hybridiZation 
experiments or When cloned in expression vectors, by cross 
reaction to tobacco EAS-speci?c antibody, or any other 
means knoWn to the art, including the use of PCR technol 
ogy carried out using oligonucleotides corresponding to 
portions of SEQ ID NO:7, preferably in the region encoding 
EAS. Antibody can be prepared after immuniZing an experi 
mental animal With EAS puri?ed as described in Vogeli et al. 
(1990) Plant Physiology 93:182—187 or using a peptide 
conjugate, Where the amino acid sequence of the peptide is 
taken from a hydrophilic portion of the EAS amino acid 
sequence (SEQ ID NO:8). Monoclonal and polyclonal anti 
body production techniques are readily accessible to the art 
(See, e.g., Campbell (1994) Monoclonal Antibody Technol 
ogy. Laboratory Techniques in Biochemistry and Molecular 
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Biology, Vol. 13, Burdon and Knippenberg, eds, Elsevier, 
Amsterdam; Harlow and Lane (1988) Antibodies: A Labo 
ratory Manual, Cold Spring Harbor Laboratory, Cold Spring 
Harbor, 
Alternately, a cDNA library (in an expression vector) can 
be screened With EAS-speci?c antibody, or EAS peptide 
speci?c antibody can be prepared using peptide sequence(s) 
from hydrophilic regions of the EAS protein (SEQ ID NO:8) 
and technology Well-knoWn in the art. 
An inducible transcription regulatory sequence can be 
operably linked to any promoter sequence functional in 
plants as understood by the skilled artisan; Where a regula 
tory element is to be coupled to a promoter, generally a 
truncated (or minimal) promoter is used, for example, the 
truncated 35S promoter of Cauli?ower Mosaic Virus, 
CaMV). Truncated versions of other constitutive promoters 
can also be used to provide CAAT and TATA-homologous 
regions; such promoter sequences can be derived from those 
of A. tumefaciens T-DNA genes such as nos, ocs and mas 
and plant virus genes such as the CaMV 19S gene. It Will be 
understood that the goals of a skilled artisan Will determine 
the choice of particular promoters used With the inducible 
transcription regulatory sequences. It is further understood 
that When a protein capable of generating a cell death 
response is to be expressed, then there is preferably no basal 
transcriptional (and translational) expression in the absence 
of inducer. The minimiZation of basal expression is less 
critical in applications for inducible gene expression Where 
the gene product has no signi?cant toxicity to the plant cells 
producing it. 
A minimal promoter contains the DNA sequence signals 
necessary for RNA polymerase binding and initiation of 
transcription. For RNA polymerase II promoters, the pro 
moter is identi?ed by a TATA-homologous sequence motif 
about 20 to 50 bp upstream of the transcription start site and 
a CAAT-homologous sequence motif about 50 to 120 bp 
upstream of the transcription start site. By convention, the 
skilled artisan often numbers the nucleotides upstream of the 
transcription start With increasingly large numbers extend 
ing upstream of (in the 5‘ direction) from the start site. 
Generally, transcription directed by a minimal promoter is 
loW and does not respond either positively or negatively to 
environmental or developmental signals in plant tissue. An 
exemplary minimal promoter suitable for use in plants is the 
truncated CaMV 35S promoter, Which contains the regions 
from —90 to +8 of the 35S gene. 
The inducible transcription regulatory sequence 
(qualitative transcription regulatory sequence) is localiZed to 
the region betWeen —167 and —100 relative to the EAS4 
transcription initiation site (nucleotides 406 to 473, initiation 
at nucleotide 573 in SEQ ID NO:2). It is understood that 
there may be a plurality of sequence motifs Which respond 
to particular stimuli. Operably linking this sequence directly 
upstream of a minimal promoter functional in a plant cell 
confers inducible expression of a coding sequence operably 
fused just doWnstream of the promoter, e.g., a heterologous 
coding sequence, and the skilled artisan understands spacing 
requirements and other requirements for translational 
expression of the coding sequence. The heterologous coding 
sequence is preferably for an elicitin-like protein of a plant 
pathogenic microorganism (virus, bacterium or fungus), for 
example, the sequence encoding the parA1 gene product 
(elicitin) of Phytophthora parasitica Where disease resis 
tance via the hypersensitivity response to an invading poten 
tial plant pathogen is desirable. Harpin proteins of certain 
phytopathogenic bacteria also can serve as inducers of 
expression mediated by the EAS4-derived inducible tran 
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scriptional regulatory sequences. Inclusion of additional 5‘ 
?anking sequence from the EAS4 gene alloWs for increased 
levels of doWnstream gene expression. Preferred is the use 
of a sequence including the —266 to +1 region of EAS4 
(nucleotides 307 to 573 of SEQ ID NO:2), and more 
preferred is the sequence including —567 to +1 (nucleotides 
A to 573 of SEQ ID NO:2). 
An alternative to the use of the fusion of the EAS4 
transcription regulatory sequence fused to a heterologous 
minimal promoter is the use of the promoter region of EAS4 
in conjunction With the upstream promoter-associated regu 
latory elements. In such an application the use of nucleotides 
307 to 463, or more preferably for greater levels of doWn 
stream expression, nucleotides 371 to 463, 311 to 462, and 
10 to 573 of SEQ ID NO:2. 
In a plant such as N. tabacum, the instant inducible 
transcription regulatory element directs the induction of 
doWnstream gene expression in response to invading plant 
pathogens and certain compositions such as some fungal 
cellulases and certain plant and fungal cell Wall fragments. 
Plant pathogens Which can trigger this expression include, 
but are not limited to, Xanthomonas, Pseudomonas 
syringae, Phytophthora species including parasitica, and 
Peronospora species (e.g., tabaci). 
Coding sequences suitable for expression in a plant are 
operably linked doWnstream of the regulated promoter con 
struct. Transgenic plants can be constructed using the chi 
meric gene consisting essentially of the regulated promoter, 
any additional transcription-enhancing sequences, and the 
desired coding sequence including the necessary sequence 
signals for its translation. Where disease resistance is to be 
advantageously induced in response to invasion of a trans 
genic plant tissue by a potential plant pathogen or in 
response to treatment With an elicitor or other chemical 
signal Which induces EAS4 gene expression, the coding 
sequence is preferably for an elicitin of a plant pathogenic 
microorganism, e.g., the parA1 gene product of Phytoph 
[hora parasitica (as described in Kamoun et al. (1993) 
supra). Other elicitin-like proteins have been described in 
the readily available scienti?c literature, and include those 
from Phytophthora species, Peronospora species, and Xan 
thomonas species, among others. 
Alternative coding sequences Which can be expressed 
under the regulatory control of the present inducible tran 
scription regulatory element for improvement of the resis 
tance of a (transgenic) plant or plant tissue exposed to a 
viral, bacterial or fungal plant pathogen include, but are not 
limited to, chitinase, TMV coat protein or other plant virus 
coat protein, NIa virus gene and others. 
Additionally, or alternatively, induction of the regulated 
construct can be induced, for example, by treating the 
transgenic plant or tissue With an elicitor or With a 
bacterium, virus or fungus (preferably not pathogenic for the 
host plant) capable of inducing expression via the inducible 
transcription regulatory element of a coding sequence not 
capable of turning on the HR, or disease resistance directly 
could be achieved. Coding sequences Which may be advan 
tageously expressed include an insecticidal protein, such as 
one of the Bacillus thuringiensis crystal proteins, Which 
When expressed Would protect the plant from insect pests. 
Phytoalexin synthesis from the native EAS4 gene, or 
induction of gene expression mediated by the present regu 
lated EAS4 promoter or the inducible transcription regula 
tory element in combination With at least a heterologous 
minimal promoter, can be induced by treating the plant 
tissue or cells With a Wide variety of de?ned chemicals, 
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crude fungal culture ?ltrates, fungal cell Wall extracts and 
oligosaccharides from plant or fungal cell Walls [Albersheim 
and Valent (1978) J. Cell. Biol. 781627—643]. Other com 
pounds capable of inducing the HR include certain 
cellulases, for example, Trichoderma reesei or T richoderma 
viride cellulases, and certain plant or fungal cell Wall 
fragments, among others. 
A transgenic plant can be produced by any means knoWn 
to the art, including but not limited to Agrobacterium 
tumefaciens-mediated DNA transfer, preferably With a dis 
armed T-DNA vector, electroporation, direct DNA transfer, 
and particle bombardment (See Davey et al. (1989) Plant 
Mol. Biol. 131275; Walden and Schell (1990) Eur J. Bio 
chem. 1921563; Joersbo and Burnstedt (1991) Physiol. 
Plant. 811256; Potrykus (1991) Annu. Rev. Plant Physiol. 
Plant Mol. Biol. 421205; Gasser and Fraley (1989) Sci. 
24411293; Leemane (1993) Bio/Technology. 111522; Beck et 
al. (1993) Bio/Technology. 1111524; KoZiel et al. (1993) 
Bio/Technology, 111194; and Vasil et al. (1993) Bio/ 
Technology. 1111533.). Techniques are Well-knoWn to the art 
for the introduction of DNA into monocots as Well as dicots, 
as are the techniques for culturing such plant tissues and 
regenerating those tissues. Monocots Which have been suc 
cessfully transformed and regenerated include Wheat, corn, 
rye, rice and asparagus. For example, US. Pat. No. 5,350, 
689 (1994, Shillito et al.) describes transgenic Zea mays 
plants regenerated from protoplasts and protoplast-derived 
cells. For ef?cient production of transgenic plants, it is 
desired that the plant tissue used for transformation possess 
a high capacity for regeneration. Transgenic aspen tissue has 
been prepared and transgenic plants have been regenerated 
[Devellard et al. (1992) CR. Acad. Sci. Ser. VIE 
3141291—298K; Nilsson et al. (1992) Transgenic Res. 
11209—220; Tsai et al. (1994) Plant Cell Rep. 14194—97]. 
Poplars have also been transformed [Wilde et al. (1992) 
PlantPhysiol. 981114—120]. Technology is also available for 
the manipulation, transformation and regeneration of Gym 
nosperm plants in the laboratory. For example, US. Pat. No. 
5,122,466 (1992, Stomp et al.) describes the ballistic trans 
formation of conifers, With preferred target tissue being 
meristematic and cotyledon and hypocotyl tissues. US. Pat. 
No. 5,041,382 (1991, Gupta et al.) describes enrichment of 
conifer embryonal cells. 
Techniques and agents for introducing and selecting for 
the presence of heterologous DNA in plant cells and/or 
tissue are Well-knoWn. Genetic markers alloWing for the 
selection of heterologous DNA in plant cells are Well 
knoWn, e.g., genes carrying resistance to an antibiotic such 
as kanamycin, hygromycin, gentamicin, or bleomycin. The 
marker alloWs for selection of successfully transformed 
plant cells groWing in the medium containing the appropri 
ate antibiotic because they Will carry the corresponding 
resistance gene. 
Other techniques for genetically engineering plant cells 
and/or tissue With an expression cassette comprising an 
inducible promoter or chimeric promoter fused to a heter 
ologous coding sequence and a transcription termination 
sequence are to be introduced into the plant cell or tissue by 
Agrobacterium-mediated transformation, electroporation, 
microinjection, particle bombardment or other techniques 
knoWn to the art. The expression cassette advantageously 
further contains a marker alloWing selection of the heter 
ologous DNA in the plant cell, e.g., a gene carrying resis 
tance to an antibiotic such as kanamycin, hygromycin, 
gentamicin, or bleomycin. 
The transcription regulatory sequences, particularly the 
inducible transcription regulatory element (or the EAS4 
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promoter With the inducible and preferably the transcription 
enhancing element) is useful in controlling gene expression 
in transgenic plant cells in suspension cell culture as an 
alternative to expression in transgenic plants. For example, 
the EAS4 promoter including the transcription initiation 
signals, the inducible transcription regulatory element and 
the transcription-enhancing element, can be used to mediate 
the inducible expression of one or more heterologous coding 
sequence(s) in transgenic plant cells in suspension cell 
culture. When desired, expression of the coding sequence of 
interest is induced by the addition of an elicitor or other 
inducing chemical signal to the culture. Suspension culture 
cells respond to elicitors readily in comparison to intact 
plants. The heterologous coding sequence(s) can encode 
proteins Which mediate synthesis of pharmaceutical 
compounds, poly-[3-hydroxybutyrate synthesis or other sec 
ondary metabolites, cellulose, starch, sugars, oils, or the 
heterologous sequences can encode pharmaceutical 
proteins, insecticidal toxin proteins, antifungal proteins, 
antiviral proteins such as coat proteins to mediate resistance 
to virus infection, the N1a protein, chitinases, glucanases, 
male sterility proteins or sequences, proteins to improve 
nutritional quality or content, or developmental and/or 
tissue-speci?c programs or patterns. It is understood that 
transgenic plants can be similarly used to express heterolo 
gous coding sequences as can transgenic plant cells. 
Where transgenic plants are to be induced for phytoalexin 
synthesis or for the expression of a heterologous coding 
sequence under the regulatory control of the EAS4 promoter 
or the inducible transcription regulatory element derived 
therefrom and/or the transcription-enhancing sequence 
derived from the EAS4 promoter as Well, the elicitor must 
penetrate the cuticle of the plant to have an inductive effect. 
Alternatively, the plant tissue can be Wounded to facilitate or 
alloW the uptake of the elicitor into the plant tissue. AWide 
variety of inducing compositions, including elicitors and 
other chemical signals, such as the combination of ethylene 
and methyl jasmonate, can be effectively introduced into the 
transgenic plant suspension cell cultures, Where there is 
signi?cantly less of a barrier to the uptake and/or sensing of 
the elicitors. Where ethylene is used at a concentration 
betWeen about 1 and about 50 ppm and the methyl jasmonate 
is used at a concentration betWeen about 0.1 mM and about 
1 mM. 
The folloWing examples use many techniques Well 
knoWn and accessible to those skilled in the arts of molecu 
lar biology, in the manipulation of recombinant DNA in 
plant tissue and in the culture and regeneration of transgenic 
plants. EnZymes are obtained from commercial sources and 
are used according to the vendors’ recommendations or 
other variations knoWn to the art. Reagents, buffers and 
culture conditions are also knoWn to the art. References 
providing standard molecular biological procedures include 
Sambrook et al. (1989) Molecular Cloning, second edition, 
Cold Spring Harbor Laboratory, Plainview; NY; R. Wu 
(ed.) (1993) Methods in Enzymology 218; Wu et al. (eds.) 
Methods in Enzymology 100 and 101; Glover (ed.) (1985) 
DNA Cloning, Vols. I and II, IRL Press, Oxford, UK; and 
Hames and Higgins (eds.) (1985) Nucleic Acid 
Hybridization, IRL Press, Oxford, UK. References related to 
the manipulation and transformation of plant tissue include 
R. A. Dixon (ed.) (1985) Plant Cell Culture: A Practical 
Approach, IRL Press, Oxford, UK; Schuler and Zielinski 
(1989) Methods in Plant Molecular Biology, Academic 
Press, San Diego, Calif.; Weissbach and Weissbach (eds.) 
(1988) Methods for Plant Molecular Biology, Academic 
Press, San Diego, Calif.; I. Potrykus (1991) Ann. Rev. Plant 
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Physiol. Plant Mol. Biol. 421205; Weising et al. (1988)Annu. 
Rev. Genet. 221421; van Wordragen et al. (1992) Plant Mol. 
Biol. Rep. 19112, Davey et al. (1989) Plant Mol. Biol. 
131273; Walden and Schell (1990) Eur. J. Biochem. 1921563; 
Joersbo and Brunstedt (1991) Physiol. Plant. 811256 and 
other Work cited in the foregoing references. Abbreviations 
and nomenclature, Where employed, are deemed standard in 
the ?eld and are commonly used in professional journals 
such as those cited herein. 
All references cited in the present application are 
expressly incorporated by reference herein. 
The folloWing examples are provided for illustrative 
purposes and are not intended to limit the scope of the 
invention as claimed herein. Any variation in the exempli 
?ed compositions and methods Which occur to the skilled 
artisan are intended to fall Within the scope of the present 
invention. 
EXAMPLES 
Example 1 
EAS-Speci?c Antibodies 
Monoclonal and polyclonal antibodies speci?c for 
tobacco EAS Were prepared as described by Vogeli et al. 
(1990) Plant Physiology 931182—187. Additional antibody 
preparations could be made as polyclonal antibodies using 
puri?ed EAS as antigen or using a peptide sequence conju 
gated to a carrier protein using Well-knoWn techniques. The 
amino acid sequence of a peptide for antibody production is 
selected from a particularly hydrophilic region of the protein 
(For antibody production technique, see, for example, 
Campbell (1994) Monoclonal Antibody Technology, Labo 
ratory Techniques in Biochemistry and Molecular Biology, 
Vol. 13, Burdon and Knippenberg, eds, Elsevier, Amster 
dam; HarloW and Lane (1988) Antibodies: A Laboratory 
Manual, Cold Spring Harbor Laboratory, Cold Spring 
Harbor, 
Example 2 
DNA and Protein Sequence Determination 
Sequence determinations of single-stranded and double 
stranded DNAs Were carried out by the dideoxynucleotide 
chain termination procedure [Sanger et al. (1977) Proc. Natl. 
Acad. Sci. USA 7418073—8077], With a Sequenase kit from 
United States Biochemical Corp., Cleveland, Ohio) or an 
automated ?uorescence-based system (Applied Biosystems, 
Foster City, Calif.). 
Example 3 
Construction of a Full-Length EAS Clone 
Nicotiana tabacum L. cv. KY14 cell suspension cultures 
Were treated With Trichoderma viride cellulase (Type RS, 
OnoZuka) at a ?nal concentration 0.5 ug/ml during rapid 
groWth phase to induce the expression of EAS. Parallel 
suspension cell cultures Which did not receive cellulase 
served as controls. Cells Were collected by gentle vacuum 
?ltration 4 hrs after the addition of the cellulase elicitor to 
the induced culture. 
A cDNA library Was prepared in pcDNAII (Invitrogen, 
San Diego, Calif.) from polyA+ RNA extracted from the N. 
tabacum cells treated for 4 hrs With elicitor. The library Was 
screened by differential hybridiZation using polyA+ RNA 
prepared from the induced and control culture. Clones 
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appearing to be positive Were further screened by hybrid 
selection-in vitro translation-immunoprecipitation analysis 
as described by AlWine et al. (1979) Methods Enzymol. 
681220—242. 
A putative positive EAS cDNA clone Was used as a 
hybridiZation probe for the isolation of additional cDNA and 
genomic clones. The genomic library thus screened Was one 
constructed in )LEMBL3 using MboI partially digested DNA 
prepared from N. tabacum L. cv. NK326 hypocotyl DNA 
(Clontech, Palo Alto, Calif.). This screening yielded 8 inde 
pendent clones, each of Which appeared to represent a 
different chromosomal locus. EAS4 and EAS3 genomic 
clones Were described in Facchini and Chappell (1992) 
supra, but are noW knoWn to have been incomplete. 
Facchini and Chappell (1992) supra had misidenti?ed the 
translation start sites of the EAS3 and EAS4 coding 
sequences in the genomic clone described therein. The 
correct translation start site for the EAS3 and EAS4 coding 
sequences have been determined to be methionine codons 
165 bp upstream of the ATG codons previously identi?ed as 
start sites. The corrected start site for EAS4 Was mapped 
using a combination of primer extension assays to identify 
the transcription start site and additional N-terminal amino 
acid sequencing data of puri?ed enZyme as noted herein 
above. 
An amplimer of 110 bp Was prepared by a polymerase 
chain reaction to provide a DNA sequence corresponding 
amino acids 5 6—92 of the EAS4 protein (see SEQ ID NO:12) 
and Facchini and Chappell (1992) supra. This amplimer Was 
used as a hybridiZation probe to screen a cDNA library in 
pcDNAII (Invitrogen, San Diego, Calif.) prepared from 
polyA+ RNA from tobacco cell culture cells 4 hr after 
elicitor treatment (T richoderma reesei cellulase). This 
amplimer Was made using a sense primer 
(ATGCTGTTAGCAACCGGAAGG; SEQ ID N013) and a 
reverse primer (ATCCAAAATCTCATCAATTTC; SEQ ID 
N014), and the genomic EAS4 template in a standard PCR 
reaction [Saiki et al. (1988) Science 2391487—491]. The 110 
bp amplimer Was isolated after polyacrylamide gel electro 
phoresis using DE-81 paper (Whatman International, Inc., 
Clifton, N.] The isolated fragment Was then radiolabeled 
With [(X-32P]-dCTP using a random priming kit from Strat 
agene (La Jolla, Calif.) for use as a hybridiZation probe in 
colony lifts of the cDNA library as previously described 
[Hanahan and Meselson (1980) Gene 10163—67]. The long 
est clone obtained in these experiments appeared to lack 80 
bp of 5‘ coding sequence. 
To obtain a full-length clone, a RT/PCR approach Was 
used. First strand cDNA Was prepared from polyA+ RNA 
prepared from tobacco cells after induction With elicitor as 
described [Facchini and Chappell (1992) supra] using 
reverse primer having the sequence ATGAGTCCTTACAT 
GTGA (SEQ ID NO15). This sequence corresponds to 
nucleotides 459—477 doWnstream of the translation start site. 
The reverse transcriptase reaction Was carried out in a 10 ul 
reaction (1 ug polyA+ RNA, 25 pmol reverse primer, 10 mM 
DTT, 2.5 mM each dATP, dGTP, dCTP, dTTP, 8 units RNase 
Block I (Stratagene, La Jolla, Calif.), ?rst strand synthesis 
buffer used according to the manufacturer’s instructions 
(Stratagene) for 1 hr at 37° C. This reaction Was terminated 
by treating at 99° C. for 5 min. Then 40 ul of master PCR 
mix Was added to the ?rst strand reaction; PCR master mix 
contains 10 mM Tris-HCl pH 8.3, 50 mM KCl, 1.5 mM 
MgCl2, 0.01% Tween-20, 0.01% (W/v) gelatin, 0.01% 
NP-40, 2.5 mM each deoxynucleotide triphosphate, 1 unit of 
TaqI polymerase, and 25 pmol forWard primer (GGGAGC 
TCGAATTCCATGG CCTCAGCAGCAGCAGTTGCAAA 
US 6,605,764 B1 
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CTAT, SEQ ID NO:6, EcoRI and NcoI recognition sites 
underlined and ATG translation start site in bold). PCR Was 
carried out under standard conditions [Back et al. (1994) 
Arch. Biochem. Biophys. 315:523—532] 
The 492 bp reaction product Was digested With EcoRI and 
HindIII and subcloned into similarly cut pBluescript SK 
(Stratagene). A HindIII/XhoI fragment from another partial 
cDNA clone Was subsequently cloned into the correspond 
ing sites of the 5‘-terminal sequence clone to generate a 
full-length cDNA clone named pBSK-TEAS. pBSK-TEAS 
DNA Was transformed into Escherichia coli TB1 using a 
CaCl2 protocol [Sambrook et al. (1989) supra]. Determina 
tion of the DNA sequence of the insert con?rmed that this 
plasmid had the expected and desired structure 
(dideoxynucleotide chain termination procedure, United 
States Biochemical Corp., Cleveland, Ohio). 
Example 4 
Identi?cation of EAS Homologous Sequences 
Tobacco leaf genomic DNA Was isolated as described in 
Murray and Thompson (1980) Nucleic Acids Research 
8:4321—4325. After digestion of aliquots With desired 
restriction enZymes, the digested DNA samples Were elec 
trophoresed on 0.8% agarose gels and the siZe-separated 
DNAs Were transferred to nylon membranes. DNA blots 
Were hybridiZed With random primer radiolabeled cEAS1, 
Which is truncated at the 5‘ end of the coding region, 
(prepared as in Sambrook et al. (1989) supra) at 60° C. in 
0.25 M sodium phosphate buffer, pH 8.0, 0.7% SDS, 1% 
bovine serum albumin, 1 mM EDTA. The blot Was then 
Washed tWice at 45° C. with 2x SSC, 0.1% SDS and tWice 
With 0.2x SSC, 0.1% SDS (1x SSC is 0.15 M NaCl, 0.015 
M sodium citrate, pH 7.0). Relative hybridiZation levels 
Were estimated from autoradiograms using a video densito 
meter (MilliGen/Biosearch, Ann Arbor, Mich.). 
Facchini and Chappell (1992) supra reported that South 
ern hybridiZation results indicated that there Were 12—16 
copies of EAS-homologs in the N. tabacum genome. To 
address the presence of signi?cantly homologous sequences 
to tobacco EAS and apparent number of copies per genome 
of those sequences, Southern hybridiZation experiments are 
carried out using DNA isolated from other plant species. 
Restriction endonuclease-digested genomic DNAs are 
separated by agarose gel electrophoresis (0.8% agarose), and 
then transferred to a Hybond-N+ membrane (Amersham 
Corp., Arlington Heights, 111.). Radiolabeled probe compris 
ing coding sequences of EAS, and hybridiZations are carried 
out essentially as described in Sambrook et al. (1989) supra. 
Moderate stringency conditions are used (hybridiZation in 
4x SSC, at 65° C.; last Wash in 1x SSC, at 65° C.). 
Alternatively, PCR can be carried out using target DNA as 
template and primers derived from the EAS4 coding 
sequence in highly conserved regions (see SEQ ID NO:7) 
using Well-knoWn techniques. 
Example 5 
Detection of EAS Protein 
The enZymatic activity of an expression product can be 
con?rmed using the techniques described in Facchini and 
Chappell (1992) supra and in Back et al. (1994) Arch. 
Biochem. Biophys. 315:527—532. 
For detecting the presence of EAS cross-reacting protein 
material, total protein fractions are prepared from 100 pl 
aliquots of bacterial culture harvested and concentrated by 
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centrifugation for 2 min in a microfuge. After discarding the 
culture supernatant, cell pellets are resuspended in 100 #150 
mM Tris-HCl, pH 6.8, 10 mM dithiothreitol, 2% sodium 
dodecyl sulfate, 0.01% bromophenol blue, 10% glycerol. 
For immunological detection 15 pl aliquots are electrophore 
sed over 11.5% SDS-polyacrylamide gels; for Coomassie 
blue-staining of the proteins, 35 pl aliquots are similarly 
electrophoresed. For soluble protein samples, the cells are 
processed as in the procedure for determination of enZy 
matic activity (see Back et al. (1995) supra or Facchini and 
Chappell (1992) supra). For immunological detection 10 pl 
aliquots are electrophoresed as above; for Coomassie blue 
staining, 10—50 pl aliquots Were electrophoresed. 
After electrophoresis the proteins are stained with C00 
massie blue, or the proteins are transferred to nitrocellulose 
membranes as described [ToWbin and Gordon (1984) Jour 
nal of Immunological Methods 72:313—340] for immunode 
tection. After incubating for 30 min in 5% loW-fat milk in 1x 
TBS (20 mM Tris-HCl, pH 7.5, 500 mM NaCl), the nitro 
cellulose blots Were incubated overnight in the same solu 
tion containing monoclonal antibody speci?c for tobacco 
EAS (1:1000 dilution; Vogeli et al. (1990) Plant Physiology 
93:182—187). Goat anti-mouse antibodies linked to alkaline 
phosphatase and the speci?c chromogenic dye Were then 
incubated to visualiZe the binding of the EAS-speci?c 
antibody to the proteins immobiliZed on the nitrocellulose 
membranes [Leary et al. (1983) Proc. Natl. Acad. Sci. USA 
80:4045—4049]. 
Example 6 
Genomic EAS4 Clone 
The 5‘-truncated cDNA clone cEAS1 described in Fac 
chini and Chappell (1992) supra Was used as a hybridiZation 
probe for screening a N. tabacum cv. NK326 genomic 
library in the )tEMBL3 vector (Clontech, Palo Alto, Calif.). 
DNA sequences Were determined using routine subcloning 
and DNA sequencing protocols. 
The DNA and deduced amino acid sequences of the EAS4 
genomic clone are presented in SEQ ID NO: 7—8. 
Example 7 
Generation of Transgenic Plants 
For studies of the function of portions of the upstream 
untranslated region of the EAS4 gene, HindIII/BamHI 
ended fragments of this upstream DNA Were cloned into 
pBI101 (Clontech, Palo Alto, Calif.) so that expression of 
the [3-glucuronidase (GUS) reporter gene could be moni 
tored in transformed plant cells. The 5‘-?anking sequence of 
the EAS3 gene is given in SEQ ID NO:1 and the 5‘-?anking 
sequence of the EAS4 gene is given in SEQ ID NO:2. In 
each of these sequences, the translation start site (ATG) is 
the last three nucleotides. By primer extension techniques, 
the EAS4 transcription start site Was estimated at nucleotide 
573 in SEQ ID NO:2. CAAT and TATA box motifs are 
identi?ed at nucleotides 429 to 432 and at nucleotides 456 
to 459 in SEQ ID NO:1 (EAS3) and at nucleotides 513 to 
516 and at nucleotides 540 to 543 in SEQ ID NO:2 (EAS4). 
The transformed plant cell lines Were produced using a 
modi?ed Agrobacterium tumefaciens transformation proto 
col. The recombinant plasmids containing the sequences to 
be introduced into plant tissue Were transferred into A. 
tumefaciens strain GV3850, by triparental mating With E. 
coli TB1 (pRK2013). N. tabacum leaves at a variety of 
stages of groWth Were cut into 1 cm2 pieces, and dipped in 
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a suspension of agrobacterial cells (about 104 to 10 cells/ml). 
After 3 to 10 minutes, the leaf segments Were then Washed 
in sterile Water to remove excess bacterial cells and to reduce 
problems With excess bacterial growth on the treated leaf 
segments. After a short drying time (30 to 60 seconds), the 
treated leaf segments are placed on the surface of Plant 
Tissue Culture Medium Without antibiotics to promote tissue 
infection and DNA transfer from the bacteria to the plant 
tissue. Plant Tissue Culture Medium contains per liter: 4.31 
g Murashige and Skoog Basal Salts Mixture (Sigma Chemi 
cal Company, St. Louis, M0), 2.5 mg benZylaminopurine 
(dissolved in 1 N NaOH), 10 ml of 0.1 mg/ml indoleacetic 
acid solution, 30 g sucrose, 2 ml Gamborg’s Vitamin Solu 
tion (Sigma Chemical Co., St. Louis, Mo.) and 8 g agar. The 
pH is adjusted betWeen pH 5.5 and 5.9 With NaOH. After 2 
days, the leaf segments Were transferred to Plant Tissue 
Culture Medium containing 300 ng/ml kanamycin, 500 
ng/ml mefoxin (Merck, RahWay, N] The kanamycin 
selects for transformed plant tissue, and the mefoxin selects 
against the agrobacterial cells. 
It is necessary to minimiZe the exposure of the explant 
tissue to agrobacterial cells during the transformation pro 
cedure in order to limit the possible induction of the regu 
lated parA1 coding sequence during the production of the 
transgenic plant cells, Which Would cause a cell death 
response. Accordingly, the ballistic technique for the intro 
duction of heterologous DNA containing cell suicide genes 
under the regulatory control of the inducible transcriptional 
regulatory element is a useful alternative transformation 
technique because it does not entail the use of agrobacterial 
cells or fungal cell Wall digestive enZymes (as necessary for 
the generation of protoplasts for electroporation), both of 
Which lead to induction of the coding sequences under the 
control of that regulatory element. 
Transgenic plants Were regenerated essentially as 
described by Horsch et al. (1985) Science 227:1229—1231. 
The resulting transgenic plants Were tested for the expres 
sion of the [3-glucuronidase (GUS) reporter gene using 
5-bromo-4-chloro-3-indolyl-[3-D-glucuronic acid as 
described by Jefferson et al. (1987) EMBO Journal 
6:3901—3907, using untreated (control) conditions and 
inducing conditions. An inducing condition is the intercel 
lular application of T viride cellulase to tobacco tissue in the 
transgenic plants (using a mechanical pipetter to apply 
50—100 pl inducing composition to interstitial tissue); con 
trols Were mock-applied but not treated With cellulase elici 
tor. Tobacco tissue Was Wounded With a scalpel in some 
experiments to facilitate exposure to the inducing com 
pounds. 
Example 8 
Deletion Analysis of Promoter and Promoter 
Associated Region 
In separate reactions, the EAS4-derived DNA sequence 
encompassed by —567 to +67 relative to the transcription 
start site (nucleotides 6 to 642, SEQ ID NO:2, EAS4) Was 
substituted for the Cauli?oWer Mosaic Virus (CaMV) 35S 
promoter [Benfey et al. (1990) EMBO Journal 
9:1677—1684] in the GUS-reporter vector pBI221 (Clontech, 
Palo Alto, Calif.). Deletion mutants in the EAS4 upstream 
regions Were then isolated after restriction endonuclease 
cutting and Bal31 digestion. Analysis of the cEAS promoter 
GUS constructs Was carried out in electroporated tobacco 
cell protoplasts and in stably transformed tobacco lines. 
Preliminary data for the transient expression demonstrated 
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that SEQ ID NO:1 and SEQ ID NO:2 functioned in regu 
lated gene expression. 
The transient expression data obtained With the N. 
tabacum protoplasts into Which various EAS3 and EAS4 
promoter-GUS constructs Were introduced are given in FIG. 
1. Progressive deletions from the 5‘ end of the EAS4 
promoter regions reduce the levels of expression, but induc 
ibility is maintained for the —262, —202 and —110 constructs 
(relative to the transcription start site at nucleotide 573 of 
SEQ ID NO:2). The data indicate that only very loW levels 
of GUS are expressed via either EAS3 promoter region 
construct. Similarly, the truncated CaMV 35S promoter 
alone is not induced by the elicitor treatment, Which pro 
vides induction via the inducible transcription regulatory 
element of EAS4. 
The data in FIGS. 2A—2B indicate that deletion of genetic 
material betWeen —567 and —160 reduce the level of doWn 
stream gene expression but does not destroy the inducibility 
of expression. Therefore, the DNA sequences betWeen —5 67 
and —160 appear to contain transcription-enhancing activity. 
Most of the transcription-increasing activity appears to 
reside betWeen —567 and —212, but additional enhancement 
appears to be mediated by sequence information betWeen 
—212 and —160 relative to the transcription start site 
(transcription start site is nucleotide 573; —567 is nucleotide 
1, —212 is nucleotide 361, and —160 is nucleotide 413, all in 
SEQ ID NO:2). 
In the Gain of Function assay data in FIG. 2B, the DNA 
sequence information necessary to mediate induction in 
response to elicitor treatment is located betWeen —160 and 
—87 relative to the EAS4 transcription start site (i.e., 
betWeen nucleotides 413 and 486 of SEQ ID NO:2). In these 
experiments the EAS-derived sequences Were placed in 
front of a truncated CaMV 35S promoter [Benfey et al. 
(1990) EMBO J. 9:1677—1684]. This ?gure also demon 
strates that the EAS4-derived transcription regulatory region 
functions When fused to a heterologous minimal promoter. 
In other experiments, either the entire —567 to +67 EAS4 
upstream region or 5‘ deletions thereof Were inserted 
upstream of the GUS ([3-glucuronidase) reporter gene in 
vector pBI101 (Clontech, Palo Alto, Calif.), and expression 
levels of the GUS reporter Were assayed under inducing and 
noninducing conditions. 160 bp upstream of the transcrip 
tion start site of EAS4 were sufficient to direct the regulated 
expression of the GUS reporter gene, although the presence 
of additional upstream sequences mediated increased 
expression. 
Constructs containing a minimum of 167 bp upstream of 
the EAS4 transcription start site gave transient gene expres 
sion in electroporated protoplasts and confer elicitor 
inducibility of GUS reporter gene expression (minimum of 
2.5 —fold increase in gene expression). By contrast, the EAS3 
upstream region (SEQ ID NO:1) does not appear to support 
high levels of reporter gene expression in the transient 
expression system, nor does it appear to confer elicitor 
inducibility to the doWnstream reporter gene. 
In part, the elicitor-inducible GUS reporter gene expres 
sion Was expected in the protoplast system because those 
protoplasts Were generated using fungal cell Wall digestive 
enZymes, and those enZymes have been shoWn to elicit 
phytoalexin production and sesquiterpene cyclase gene 
expression in plants [Chappell et al. (1991) Plant Physiology 
97:693—698]. A possible explanation is that the 6 hr time 
period before the experiment alloWs the cells to return to an 
elicitor-responsive state. 
PBI101 is commercially available from Clontech (Palo 
Alto, Calif.). It contains the CaMV 35S promoter upstream 
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of the GUS reporter gene in a pUC19 vector; thus it serves 
as a vector for transient expression experiments Where the 
recombinant vector is introduced into plant protoplasts. The 
presence of this plasmid and its derivatives is selected by 
groWth on kanamycin. A “promoter-less” GUS cassette in 
the Agrobacterium binary plasmid vector pBIN19 (Bevan, 
M. (1994) Nucl. Acids Res. 12:8711) similarly carries a 
plant-expressible kanamycin resistance determinant. 
Example 9 
Identi?cation of Inducible Transcription Regulatory 
Element 
The 5‘ ?anking domains of genomic EAS3 and EAS4 
clones Were mapped by S1 nuclease protection and primer 
extension experiments [Sambrook et al. (1989) supra]. Sub 
clones comprising up to 1 kb 5‘ to the translation start site 
Were sequenced and fused to the [3-glucuronidase (GUS) 
reporter gene in PBI101 for studies in transgenic plant 
tissue. The resulting recombinant plasmids Were then elec 
troporated into tobacco protoplasts. GUS activity Was mea 
sured in transient expression assays, and stable transformed 
tobacco cell lines Were also isolated for studies of GUS 
induction and expression. 
Constructs Were prepared containing a minimum of about 
200 bp of nucleotide sequence upstream of the EAS4 
transcription start site in the modi?ed pBI101 vector, and a 
[3-glucuronidase (GUS) reporter gene Were made and ana 
lyZed for ability to drive regulated GUS expression. 200 bp 
of ?anking sequence appeared suf?cient to drive transient 
gene expression in electroporated protoplasts and confers 
elicitor inducibility to GUS expression (minimum of 2.5 
fold induction). Similar experiments With the EAS3 ?anking 
sequence indicated that 200 bp from the EAS3 locus did not 
support either high levels of GUS expression or elicitor 
responsiveness in transformed plant cells. Cellulase and 
elicitins from Phytophthora [Ricci et al. (1989) Eur. J. 
Biochem. 183:555—563] serve to induce gene expression 
mediated by the EAS4-derived regulatory sequences. 
Further studies related to the identi?cation of sequences 
important in mediating induced gene expression in response 
to pathogen invasion, as modeled using cellulase or elicitins, 
Were carried out after oligonucleotide site-directed mutagen 
esis [Kunkel (1985) Proc. Natl. Acad. Sci. USA 82:488—492] 
of the putative regulatory region of EAS4. Substitution of 
GT for the Wild-type CA at —233 and —234 relative to the 
EAS4 transcription start site (nucleotides 334—335 of SEQ 
ID NO:2) did not appear to alter the expression of the GUS 
reporter gene as measured after incubation in the presence of 
elicitor (cellulase) for 20 hours. 
Preliminary methylation interference and gel retardation 
studies carried out essentially as described [Sambrook et al. 
(1989) supra] indicated that an octameric sequence centered 
around —233 relative to the translation start site (centered 
around 334 of SEQ ID NO:2) binds proteins from plant cell 
nuclei. Methylation interference data suggested that the G at 
position —233 Was preferentially protected against methyla 
tion by DMS (dimethyl sulfate) if ?rst alloWed to interact 
With nuclear extracts. The results of gel retardation studies 
Were consistent With those obtained in the methylation 
protection experiments. When DNA fragments containing 
the —343 to —140 region (relative to the translation start site) 
(nucleotides 230 to 433 of SEQ ID NO:2) Were examined 
after reaction to nuclear extracts, mobility in native acryla 
mide gel electrophoresis appeared retarded. Protein binding 
Was abolished by the GT to CA substitution at positions 
—234 and —233. Similar results Were observed in control and 
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elicitor-induced cell extracts, and reporter gene expression 
Was not changed by this 2 bp mutation. Thus, it is concluded 
that the region around —233 is not directly involved in the 
induction of gene expression in response to pathogen inva 
sion or elicitor treatment. 
Preliminary experiments indicate that EAS4 DNA 
sequences betWeen —253 and —48 relative to the EAS4 
transcription start site (betWeen nucleotides 320 and 525 of 
SEQ ID NO:2) have qualitative and quantitative effects on 
doWnstream reporter gene expression. Sequences betWeen 
—110 and —1 of EAS4 relative to the transcription start site 
of EAS4 (nucleotides 463 to 572 of SEQ ID NO:2) to 
mediate the inducible response, While sequences betWeen 
—202 and —110 relative to the EAS4 transcription start site 
(nucleotides 371 to 463 of SEQ ID NO:2) enhance the levels 
of both induced and uninduced reporter gene expression. 
Example 10 
Disease-resistant Transgenic Plants 
The parA1 coding sequence Was isolated from Phytoph 
tora parasitica race O as folloWs: Genomic DNA Was 
isolated and used as template in PCR With a SIG forWard 
primer (CGTTGGATCCCCACCTCATCCGAAATGAAC; 
SEQ ID NO:9; BamHI site underlined; nucleotides 25—27 
correspond to the translation start site and reverse primer 
(GGCTGAGCTCCTGGACGFCAGAGATCAAACC; SEQ 
ID NO:10; SstI site underlined) to amplify the coding region 
of the ParA1 elicitin including the signal peptide coding 
sequence. To isolate an amplimer corresponding to the 
coding sequence of the ParA1 elicitin, the MAT forWard 
primer (GCCGGATCCTTAGTACTAGTTGCACCACCA 
CGCAGCAAACTG, SEQ ID NO:11; BamHI site, 
GGATCC, and SpeI site, ACTAGT, underlined; translation 
start site at nucleotides 12—14 and the reverse primer as 
before (SEQ ID NO:10) Were used With genomic DNA as 
template. The amplimer sequences of the elicitin-With-signal 
peptide and the nature elicitin are given in SEQ ID NO:15 
and SEQ ID NO:17, respectively. 
For subcloning into pBluescript (Stratagene, La Jolla, 
Calif.) or into pEAS4 constructs, the amplimer DNA Was 
digested With BamHI and SstI. Where the mature protein’s 
coding sequence is used, the mature elicitin/pEAS4 con 
struct can be digested With SpeI to insert a plant signal 
sequence at the 5‘ end of the open reading frame. The 
pEAS4-GUS vector is digested With BamHI and SstI, With 
the large fragment of DNA being puri?ed after agarose gel 
electrophoresis. 
FIG. 3 illustrates the molecular manipulations leading to 
the generation of disease-resistant plants. The coding 
sequence for the ParA1 elicitin is isolated by PCR so as to 
have BamHI and SstI ends. gEAS4600 -GUS-pBI101, Which 
directs the expression of the GUS reporter gene under the 
regulatory control of the EAS promoter, is digested With 
BamHI and SstI to release the GUS reporter gene. Then the 
BamHI/SstI-digested ParA1 amplimer is ligated to the large 
fragment produced after digestion of gEAS4600 -GUS 
pBI101 to produce gEAS46O0-parA1-pBI101, from Which 
the ParA1 elicitin is synthesiZed after induction With a 
suitable elicitor once plant cells or tissue have been trans 
formed. 
While various embodiments of the present invention have 
been described in detail, it is apparent that modi?cations, 
extensions, adaptations and optimiZations may occur in 
those skilled in the art. It is to be expressly understood that 
such modi?cations and adaptations and so on are Within the 
spirit and scope of the present invention, as set forth in the 
claims. 
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SEQUENCE LISTING 
( 1) GENERAL INFORMATION: 
(iii) NUMBER OF SEQUENCES: l3 
(2) INFORMATION FOR SEQ ID NO: 1: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 512 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: double 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Vi) ORIGINAL SOURCE: 
(A) ORGANISM: Nicotiana tabacum 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:l: 
CCGCGATTGG AGGATGTTGT ACGTCGAGCT ACGCGGCACC 
AAGAAGGAAC GGGGATGGTG GTCAACGAAA CACGACGGGC 
CCGCCGTGGG TGAAGAAGTC GACGTTGGAA AAGAGCTACA 
GGGATGGCCG CTGACTACAG AAAGTGCGTT TCCCGCCACC 
AAGATCAATG CTGACCGAAC CAGACGGCGG TACGTCATCC 
CAGTTCTTGT TGTCGTGTGT CGAACTCGGG ACGTTTGTCA 
GCCGCCATCA ACGTGTCGCC GCCAATCGAC GAGCGCGACT 
CCACGGATCA ATTACATTAA CTAGTCTCTC ACCACTATAT 
ATTTAAGTAG AGTTCCTTTC TTTCTTCCTT AA 
(2) INFORMATION FOR SEQ ID NO:2: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 642 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: double 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Vi) ORIGINAL SOURCE: 
(A) ORGANISM: Nicotiana tabacum 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:2: 
TAGGTGAATG TCAGGGCTTA TGCTCCACGA TACTTATGCC 
GGGACTCGCT CAAAAAACGT CTTTGTTGTG AGAAATTGCA 
CGACAAAACC TTGGTTCGTG AAAACTGTTT GATTAACTTT 
ACTCTAAACT GACCTAAATA AATACTACGT ACACTAGTCT 
TCTGCATTAA TAATTGAAAT TTATGCCGCA ACAATGACAT 
ATAGGAATTT GATAGTTCCA GGAAACAACT CTACAGTACT 
AAATAATATT ATTCAGTTGA CGAAACAAAT AAATAAAATA 
GCGCTTAATT 
CCGACATCAT 
GCCTGCTCCA 
CGGGGCGAGC 
GCTTGAGGGT 
CATGGCTGGA 
TTCCCAGAGA 
ATACTTGTCC 
CTGCCAGTAC 
ATTTTGAACC 
TAGACCATCC 
TTAAGTTCAT 
TAGGTTTTAT 
CCCTTATTTT 
TTTGGGAAAC 
TTACTCGGTC 
GCCTGACAAC 
CGCGGATGCG 
CCGGGTTTTG 
AGAGACGGAT 
CGGGTTATTC 
CTTTAGCGTG 
CTTCTCTTCC 
ACCTCGCGGT 
TCTACAATTT 
AGTCAATTTA 
CAAAGTGGAC 
AAATAAAGTA 
GTGCCTTTTT 
TGGATCAATA 
60 
120 
180 
240 
300 
420 
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GACCCCAGAC GCCAACAATG AATCAAAAGG CTGCTAGCTA GTGTAAAGTC TAGTAAGGCA 
ACTGGGAAAT TAAATGATTA GGTGCTTTTG ATCAATTACA TTAACTAGTC TCTCACCACT 
ATATATACTT GTCCCTTCTC TTCCATTTAA GTAGAGTTCC TTTCTTTCTT CCTTAAAACT 
TAAAAGAACA AGTAAAAATA CACTCATCTT TAATTAGCAA TG 
(2) INFORMATION FOR SEQ ID NO: 3: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 21 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: other nucleic acid 
(A) DESCRIPTION: /desc = "Oligonucleotide primer for 
PCR" 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Xi) SEQUENCE DESCRIPTION: SEQ ID NO:3: 
ATGCTGTTAG CAACCGGAAG G 
(2) INFORMATION FOR SEQ ID NO: 4: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 21 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: other nucleic acid 
(A) DESCRIPTION: /desc = "Oligonucleotide primer for 
PCR" 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: YES 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:4: 
ATCCAAAATC TCATCAATTT C 
(2) INFORMATION FOR SEQ ID NO:5: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 18 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: other nucleic acid 
(A) DESCRIPTION: /desc = "Oligonucleotide primer for 
PCR. " 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: YES 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:5: 
ATGAGTCCTT ACATGTGA 
(2) INFORMATION FOR SEQ ID NO: 6: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 45 base pairs 
(B) TYPE: nucleic acid 
(c) STRANDEDNESS: single 
(D) TOPOLOGY: linear 
480 
540 
600 
642 
21 
21 
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(ii) MOLECULE TYPE: other nucleic acid 
(A) DESCRIPTION: /desc = "Oligonucleotide primer for 
PCR. " 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: YES 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:6: 
GGGAGCTCGA ATTCCATGGC CTCAGCAGCA GCAGTTGCAA ACTAT 
(2) INFORMATION FOR SEQ ID NO: 7: 
(i) SEQUENCE CHARACTERISTICS: 
(A) LENGTH: 4254 base pairs 
(B) TYPE: nucleic acid 
(C) STRANDEDNESS: double 
(D) TOPOLOGY: linear 
(ii) MOLECULE TYPE: DNA (genomic) 
(iii) HYPOTHETICAL: NO 
(iv) ANTI-SENSE: NO 
(Vi) ORIGINAL SOURCE: 
(A) ORGANISM: Nicotiana tabacum 
(ix) FEATURE: 
(A) NAME/KEY: CDS 
(B) LOCATION: join(1217 . . 1327, 1455 . . 1718 , 1806 . .2182, 
2259 
. .2477 , 2609 . .2747, 2903 . . 3148 , 3262 . .3558) 
(xi) SEQUENCE DESCRIPTION: SEQ ID NO:7: 
AAGCTTTATG AATTAGATGT AAAAAGACGC AAACTACTTA TATATATTAC CAAAGTAACT 
TGAAAGTTTA AAATTTCAAT TAGAACTATA GTAGGGTAAA ACTGTCTATT TAAAATCAGT 
ATTTAAAAAG GCATGAGCGA AAGATGAGGC GTTTTATCTA ACACGAAGCG AGGTGTAAGC 
CCCATGGTGT TTTATTTTTA TATTTTATAA ATTTATAAAA TCATTATATA AATCAGAAAA 
ATACACTAAA ATTGTGAAAA GTTAAAGAAA ATTATAGAAT TAATATATAT ATATATATAT 
A'T‘A'T‘A'T‘A'T‘A'T‘ A'T‘A'T‘A'T‘A'T‘A'T‘ A'T‘A'T‘A'T‘A'T‘A'T‘ A'T‘A'T‘A'T‘A'T‘A'T‘ AAATGTATGT GTGTGTGTGT 
GTGTACATGC GCGCGCGACC ATGCAACTTT TTTTTCTTGA AAAAATAAAA GGCGTAAAGA 
TACATTATAC CTATGTCATC AAAACAATAT AAAAACTAGA GCGATACCAA AAGAAATTTT 
AAATTCAAAA ACTAACTTGA AATTAATATA TTTAAAATTT CATTTTTTTT TGTGTGGAGA 
AAACAAAGCA TAACACTTTG CTTTGTAACA CTTTGCCTAG GTGAATGTCA GGGCTTATGC 
TCCACGATAC TTATGCCCTG CCAGTACACC TCGCGGTGGG ACTCGCTCAA AAAACGTCTT 
TGTTGTGAGA AATTGCAATT TTGAACCTCT ACAATTTCGA CAAAACCTTG GTTCGTGAAA 
ACTGTTTGAT TAACTTTTAG ACCATCCAGT CAATTTAACT CTAAACTGAC CTAAATAAAT 
ACTACGTACA CTAGTCTTTA AGTTCATCAA AGTGGACTCT GCATTAATAA TTGAAATTTA 
TGCCGCAACA ATGACATTAG GTTTTATAAA TAAAGTAATA GGAATTTGAT AGTTCCAGGA 
AACAACTCTA CAGTACTCCC TTATTTTGTG CCTTTTTAAA TAATATTATT CAGTTGACGA 
AACAAATAAA TAAAATATTT GGGAAACTGG ATCAATAGAC CCCAGACGCC AACAATGAAT 
CAAAAGGCTG CTAGCTAGTG TAAAGTCTAG TAAGGCAACT GGGAAATTAA ATGATTAGGT 
GCTTTTGATC AATTACATTA ACTAGTCTCT CACCACTATA TATACTTGTC CCTTCTCTTC 
CATTTAAGTA GAGTTCCTTT CTTTCTTCCT TAAAACTTAA AAGAACAAGT AAAAATACAC 
45 
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720 
780 
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900 
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1020 
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1140 
1200 
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TCATCTTTAA TTAGCA ATG GCC TCA GCA GCA GTT GCA AAC TAT GAA GAA 
Met Ala Ser Ala Ala Val Ala Asn Tyr Glu Glu 
1 5 10 
GAG ATT GTT CGC CCC GTC GCC GAC TTC TCC CCT AGT CTC TGG GGT GAT 
Glu Ile Val Arg Pro Val Ala Asp Phe Ser Pro Ser Leu Trp Gly Asp 
15 20 25 
CAG TTC CTT TCA TTC TCC ATT GAT AAT CAG GTAATTTAAC TAATACTAGT 
Gln Phe Leu Ser Phe Ser Ile Asp Asn Gln 
30 35 
ATTCTTTATT TATATTTATA GTTTGTTCTC CATTGATAAT CAGGTAGTTT ATTTATGTTG 
AACAACATTA ATTTTGCTAA TTTCAGTTTA ATGTACATTA CATATAG GTT GCG GAA 
Val Ala Glu 
40 
AAG TAT ATA TAT GCT CAA GAG ATT GAA GCA TTG AAG GAA CAA ACG AGG 
Lys Tyr Ile Tyr Ala Gln Glu Ile Glu Ala Leu Lys Glu Gln Thr Arg 
45 50 55 
AGT ATG CTG TTA GCA ACC GGA AGG AAA TTG GCC GAT ACA TTG AAT TTG 
Ser Met Leu Leu Ala Thr Gly Arg Lys Leu Ala Asp Thr Leu Asn Leu 
60 65 70 
ATT GAC ATT ATT GAA CGC CTT GGT ATA TCC TAC CAC TTT GAG AAA GAA 
Ile Asp Ile Ile Glu Arg Leu Gly Ile Ser Tyr His Phe Glu Lys Glu 
ATT GAT GAG ATT TTG GAT CAG ATT TAC AAC CAA AAC TCA AAC TGC AAT 
Ile Asp Glu Ile Leu Asp Gln Ile Tyr Asn Gln Asn Ser Asn Cys Asn 
90 95 100 
GAT TTG TGC ACC TCT GCA CTT CAA TTT CGA TTG CTC AGG CAA CAC GGT 
Asp Leu Cys Thr Ser Ala Leu Gln Phe Arg Leu Leu Arg Gln His Gly 
105 110 115 120 
TTC AAC ATC TCT CCT GGTAAGTTCA TCATGAAGTT GTTAAAATTA TTATCCATTT 
Phe Asn Ile Ser Pro 
125 
ATTGGAAGAA GGCTAATTCA TCTTGAGTTT TCTTTCTTGA AATACCA GAA ATT TTC 
Glu Ile Phe 
AGC AAA TTC CAA GAT GAA AAT GGC AAA TTC AAG GAG TCT CTT GCT AGT 
Ser Lys Phe Gln Asp Glu Asn Gly Lys Phe Lys Glu Ser Leu Ala Ser 
130 135 140 
GAT GTC TTA GGA TTA TTA AAC TTG TAT GAA GCT TCA CAT GTA AGG ACT 
Asp Val Leu Gly Leu Leu Asn Leu Tyr Glu Ala Ser His Val Arg Thr 
145 150 155 160 
CAT GCT GAC GAT ATC TTA GAA GAC GCA CTT GCT TTC TCC ACT ATC CAT 
His Ala Asp Asp Ile Leu Glu Asp Ala Leu Ala Phe Ser Thr Ile His 
165 170 175 
CTT GAA TCT GCA GCT CCA CAT TTG AAA TCT CCA CTT AGG GAG CAA GTG 
Leu Glu Ser Ala Ala Pro His Leu Lys Ser Pro Leu Arg Glu Gln Val 
180 185 190 
ACA CAT GCC CTT GAG CAA TGT TTG CAC AAG GGT GTT CCT AGA GTC GAG 
Thr His Ala Leu Glu Gln Cys Leu His Lys Gly Val Pro Arg Val Glu 
195 200 205 
ACC CGA TTC TTC ATC TCA TCA ATC TAT GAC AAG GAA CAA TCG AAG AAT 
Thr Arg Phe Phe Ile Ser Ser Ile Tyr Asp Lys Glu Gln Ser Lys Asn 
210 215 220 
AAT GTG TTA CTT CGA TTT GCC AAA TTG GAT TTC AAC TTG CTC CAG ATG 
Asn Val Leu Leu Arg Phe Ala Lys Leu Asp Phe Asn Leu Leu Gln Met 
225 230 235 240 
TTG CAC AAA CAA GAA CTT GCT CAA GTA TCA AG GTGCGATATA 
Leu His Lys Gln Glu Leu Ala Gln Val Ser Arg 
245 250 
TAAAAACGAT GAACCCTTTT TGATTCATCA TATCTCAAGT ACTCATGTTA ATTTCTTATG 
1249 
1297 
1347 
1407 
1463 
1511 
1559 
1607 
1655 
1703 
1758 
1814 
1862 
1910 
1958 
2006 
2054 
2102 
2150 
2192 
2252 






